Revance Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Revance Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q3 2024.
  • Revance Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -38 %, a 48.2% increase year-over-year.
  • Revance Therapeutics, Inc. annual Return On Assets for 2023 was -60.1 %, a 5.18% decline from 2022.
  • Revance Therapeutics, Inc. annual Return On Assets for 2022 was -57.1 %, a 23.4% decline from 2021.
  • Revance Therapeutics, Inc. annual Return On Assets for 2021 was -46.3 %, a 6.78% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -38 +35.4 +48.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -57.1 +1.57 +2.68% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60 -1.4 -2.39% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.1 -2.96 -5.18% Oct 1, 2023 Dec 31, 2023
Q3 2023 -73.3 -28.6 -63.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -58.7 -13.2 -29% Apr 1, 2023 Jun 30, 2023
Q1 2023 -58.6 -12.8 -27.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -57.1 -10.8 -23.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -44.8 +0.52 +1.15% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.5 -1.35 -3.06% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.8 -2.32 -5.34% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.3 -2.94 -6.78% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.3 -0.44 -0.98% Jul 1, 2021 Sep 30, 2021
Q2 2021 -44.1 +3.01 +6.38% Apr 1, 2021 Jun 30, 2021
Q1 2021 -43.5 +6.31 +12.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -43.4 +8.62 +16.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -44.9 +10.8 +19.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -47.2 +6.99 +12.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -49.8 +4.99 +9.11% Jan 1, 2020 Mar 31, 2020
Q4 2019 -52 +4.84 +8.52% Oct 1, 2019 Dec 31, 2019
Q3 2019 -55.6 -2.46 -4.63% Jul 1, 2019 Sep 30, 2019
Q2 2019 -54.1 +1.53 +2.75% Apr 1, 2019 Jun 30, 2019
Q1 2019 -54.8 +2.09 +3.68% Jan 1, 2019 Mar 31, 2019
Q4 2018 -56.8 +1.34 +2.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -53.2 +4.74 +8.19% Jul 1, 2018 Sep 30, 2018
Q2 2018 -55.7 -7.92 -16.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 -56.9 -12.9 -29.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -58.2 -19.7 -51.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -57.9 -24 -71% Jul 1, 2017 Sep 30, 2017
Q2 2017 -47.8 -11.2 -30.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -44 -8.22 -23% Jan 1, 2017 Mar 31, 2017
Q4 2016 -38.5 -1.23 -3.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -33.9 +3.35 +9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -36.6 -4.31 -13.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -35.8 -7.35 -25.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -37.3 -2.89 -8.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -37.2 +4.64 +11.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -32.3 Apr 1, 2015 Jun 30, 2015
Q1 2015 -28.4 Jan 1, 2015 Mar 31, 2015
Q4 2014 -34.4 Oct 1, 2014 Dec 31, 2014
Q3 2014 -41.9 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.